Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.23% to 9012.99, DAX +0.08% to 24307.80, CAC40 (0.31%) to 7798.22, STOXX 600 (0.08%) to 546.58

Jul 21 ,2025

  • Synopsis:

    • European equity markets ended mixed to lower, with shares, opening at the best levels of the day, moving little in either direction during the session as STOXX600 moved either side of unchanged.

    • Ireland +1.3% and Austria +0.6% lead outperformers, whilst Greece, Norway both (0.8%) and Italy, Netherlands, Switzerland all (0.4%) lead underperformers

    • US tariff headlines and conflicts in Ukraine and Gaza continue to provide backdrop to markets. Also in focus are elections over the weekend in Japan, where ruling coalition has lost its majority in the country's upper house.

    • UK parliamentary committee topics included energy security and net zero (minister Miliband), work of PM (PM Stamer) as well as environmental sustainability and housing growth (govn. ministers, getting underway around now). Chancellor Merz met with representatives of the "Made for Germany" business initiative, and around now is hosting Norway's PM Støre. A joint press conf is planned ~18:45CET.

    • Economic data releases were limited and included in UK, Rightmove's latest house price index, with the average price of property coming to the market for sale on Jun was down (1.2%) m/m to ~£373.7K and Deloitte's Q2 consumer confidence fell for the first time since Q3 of 2022 (consumer tracker)

    • Amongst the handful of earning releases were Ryanair Holdings (RYA.ID), Munich Re (MIV2.GR) prelim Q2 net income ~ €2.1B vs FactSet €1.70B [3 est, €1.65-1.73B], reaffirms FY guidance, Galp Energia (GALP.PL) and Stellantis (STLAM.IM), where share prices responded positively, the latter reversing initial falls, whilst with share pricing moving in the opposite direction were Evotec (EVT.GR) and MONY Group (MONY.LN).

    • M&A news flow included Wolters Kluwer (WKL.NA) to divest its Finance, Risk and Regulatory Reporting unit for enterprise value of ~ €450M, Greek Organisation of Football Prognostics (OPAP.GA) acquires the remaining 15.51% stake in Stoiximan for ~ €191.6M on a cash free debt free basis. Jungheinrich (JUN3.GR) agrees to sell its Russian subsidiary and Van Lanschot Kempen (VLK.NA) agrees to acquire Wilton Family Office. Also, CVC Capital Partners (CVC.NA) announces KKR agrees to acquire a significant minority stake in global travel technology company Etraveli Group and EQT X (EQT.SS) acquires Adevinta's Spanish operations.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Basic Resources +2.91%, Real Estate +1.27%, Travel & Leisure +1.08%, Utilities +0.83%, Chemicals +0.58%, Autos & Parts +0.38%, Banks +0.34%, Insurance +0.23%, Financial Svcs +0.02%, Retail (0.05%), Construct & Mtls (0.07%), Telecom (0.07%)

      • Underperformers:

        • Health Care (0.85%), Media (0.75%), Food & Beverage (0.67%), Oil & Gas (0.41%), Persnl & HHold Goods (0.40%), Technology (0.28%), Ind Goods & Svcs (0.22%)

    • Macro/Peripheral markets:

      • Geopolitics:

        • Ukraine and Russia peace talks possibly start on Tue or Wed in Istanbul - Mezka

      • ECB:

        • Survey on the Access to Finance of Enterprises -- release

      • Belgium:

        • Government negotiations make progress in some areas, taxation, employment, and pensions; party leaders not expecting to resume talks until after the summer holiday; next test - the budget - L'Echo, W16

      • Germany:

        • ifo President Fuest gives mixed interim assessment of the new German government - release

      • Ireland:

        • Revised National Development Plan set to be approved Coalition leaders and senior ministers; Headline figures will be announced tomorrow - Irish Times

      • Sweden:

        • Government consults on proposals to strengthen the security of supply in the electricity system; focus on investment on electricity production capacity where the need is greatest - press release

      • Turkey:

        • Wants to finalise the purchase of Eurofighter jets as soon as possible says President Erdogan, following positive signals from Germany and UK - Reuters

      • UK:

        • Chancellor eyes selling £5B in seized crypto to plug budget gap - GBN

        • Chancellor warned that a tax raid on retailers in the budget in Oct would fuel inflation and drive up food prices heading onto Christmas - RetailWeek

        • Ofwat to be abolished in biggest overhaul of water since privatisation - press release; UK water industry report has 88 recommendations including a single water regulator in England and Wales - Summary of report

        • Government revives landmark Pensions Commission to confront retirement crisis that risks tomorrow's pensioners being poorer than today's; its final report due in 2027 - release

        • Fifth round of negotiations on an upgraded Free Trade Agreement (FTA) with the Republic of Korea made good progress in several areas; further discussions are expected to be held in the Autumn - Ministerial Statement

    • Company news:

      • Notable Gainers

        • +19.9% ONT.LN (Oxford Nanopore Technologies) -- prelim H1 revenue £105M vs FactSet £99.0M [2 est, £98.6-99.4M]; FY guidance remains on track

        • +9.5% ST5.GR (STEICO) -- H1 net income €10.6M vs year-ago €19.8M; confirms its FY25 forecast

        • +8.0% B2I.NO (B2 Impact) -- prelim Q2 cash EBITDA NOK1.15B vs year-ago NOK1.33B

        • +8.0% ALZCUR.SS (AlzeCure Pharma) -- to present abstract on ACD440 at the NeuPSIG 2025 Pain Conf

        • +6.4% CAML.LN (Central Asia Metals) -- New World Resources Ltd. notes termination of BID with CAML; recommends holders accept Kinterra's cash offer

        • +6.2% PEBB.LN (Pebble Group PLC (The)) -- launches £6.5M (up to 10.7M shares) tender offer

        • +5.3% PARKEN.DC (PARKEN Sport & Entertainment) -- confirms rumours that an offer has been received for Victor Froholdt from a Portuguese club

        • +5.2% C3RY.GR (Cherry) - Lowers FY guidance

        • +5.2% RYA.ID (Ryanair Holdings) -- Q1 EPS €0.77 vs FactSet €0.60 [6 est, €0.45-0.66]

        • +5.2% BOL.SS (Boliden) -- buy from hold at Berenberg

        • +4.6% DAM.GR (Data Modul) -- prelim Q2 earnings

        • +4.0% COV.FP (Covivio) -- H1 adj. EPRA EPS €2.38 vs year-ago €2.24; raises FY recurring net result (adj. EPRA earnings) guidance

        • +4.0% CREO.LN (Creo Medical Group) -- H1 trading update: underlying operating loss on continuing basis reduced to £6.9M vs year-ago £12.1M; on track for 40-60% revenue growth for FY

        • +3.9% WRT1V.FH (Wartsila) -- hold from sell at ABG Sundal Collier

        • +3.4% MIDW.LN (Midwich Group) -- Guides H1 Adj. PBT ~£9.5M vs year-ago £17.2M; year-end outlook unchanged despite challenging market conditions continuing

        • +3.4% KBX.GR (Knorr-Bremse) -- buy from hold at Kepler Cheuvreux

        • +3.3% ATO.FP (ATOS) -- As at 30-Jun, liquidity estimated at €1.80B vs €2.18B as at 31-Dec

        • +2.6% BAS.GR (BASF) -- asks shortlisted bidders for coatings business to submit offers next month - Bloomberg

        • +2.3% VIV.FP (Vivendi) -- EC sends Statement of Objections to Vivendi for possible breach of EU merger rules regarding acquisition of Lagardère before merger approval

          • takes note of the Statement of Objections issued by the EC and denies its claims

          • buy from hold at Kepler Cheuvreux; buy from neutral at CIC Market Solutions

        • +2.1% ATCO.A.SS (Atlas Copco) -- buy from hold at ABG Sundal Collier

        • +2.0% DOM.SM (Global Dominion Access) -- divests its six photovoltaic plants in the Dominican Republic

        • +1.9% STLAM.IM (Stellantis) -- prelim H1 net loss (€2.30B) including (€3.3B) of pre-tax net charges, FactSet €1.36B [11 est, €627-2.63B]; Q2 shipment volumes 1.447M, (6%) y/y

        • +1.9% XVIVO.SS (Xvivo Perfusion) -- enrols first patient in US PRESERVE CAP study

        • +1.5% GALP.PL (Galp Energia) -- Q2 RCA net income €373M vs consensus €220M; raises FY Group EBITDA and OCF expectations

        • +1.5% JLP.LN (Jubilee Metals Group) -- Q4 Operational Update: Chrome concentrate production +19.9% y/y

        • +1.2% SCHP.SW (Schindler Holding) -- hold from reduce at Kepler Cheuvreux

        • +1.2% BEAN.SW (BELIMO Holding) -- H1 net income CHF101.3M vs FactSet CHF99.2M [2 est, CHF98.0-100.4M]

        • +1.2% HEAD.LN (Headlam Group) -- sells and leases back Tamworth distribution centre

        • +1.1% VLK.NA (Van Lanschot Kempen) -- agrees to acquire Wilton Family Office for an undisclosed amount in cash

        • +1.0% DOV.IM (doValue) -- outperform from neutral at Mediobanca

          • On earnings/updates: MUV2.GR (Munich Re), HLUN.B.DC (H. Lundbeck)

      • Notable Decliners

        • -16.4% EVT.GR (Evotec) -- lowers FY25 revenues to €760M-€800M range vs prior €840M-€880M; confirms R&D expenses and adj EBITDA guidance

        • -8.1% IDEX.NO (IDEX Biometrics) -- provides business update and informs that the publication of Q2 earnings is postponed to 27-Aug; launches private placement of 9.1M new shares

        • -7.2% MONY.LN (MONY Group) -- H1 adjusted EPS 9.2p vs year-ago 8.9p; FY Adj. EBITDA within its current published consensus

        • -6.8% TFI.FP (TF1) -- hold from buy at Kepler Cheuvreux

        • -6.6% AGY.LN (Allergy Therapeutics) -- FY Trading Update: revenue £55.0M vs year-ago £55.2M

        • -6.1% SAAB.B.SS (Saab) -- hold from buy at Pareto; sell from hold at Danske Bank

        • -4.3% VWS.DC (Vestas Wind Systems) -- reduce from hold at Kepler Cheuvreux

        • -3.9% SHOT.SS (Scandic Hotels Group) -- neutral from buy at UBS

        • -3.5% GHH.LN (Gooch & Housego) -- CFO steps down

        • -3.3% NSI.NA (NSI NV) -- hold from buy at Kepler Cheuvreux

        • -2.7% VIMIAN.SS (Vimian Group) -- hold from buy at DNB Carnegie

        • -1.6% ASML.NA (ASML Holding) -- neutral from buy at Van Lanschot Kempen

          • In earnings/updates: AGR.LN (Assura) and reversing initial gains JUN3.GR (Jungheinrich)

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Telekom Austria (TKA.AV)

        • Benelux: ASM International (ASM.NA), Akzo Nobel (AKZA.NA), Wereldhave (WHA.NA), ACOMO (ACOMO.NA)

        • Denmark: Embla Medical hf (EMBLA.DC)

        • Finland: Kesko (KESKOB.FH), Tietoevry (TIETO.FH)

        • France: Dassault Aviation (AM.FP), Sartorius Stedim Biotech (DIM.FP)

        • Germany: SAP (SAP.GR), Sartorius (SRT3.GR), flatexDEGIRO (FTK.GR)

        • Norway: Norsk Hydro (NHY.NO), Vår Energi (VAR.NO)

        • Southern Europe: UniCredit (UCG.IM), Poste Italiane (PST.IM), Enagas (ENG.SM), ENCE Energia y Celulosa (ENC.SM)

        • Sweden: Alfa Laval (ALFA.SS), Asker Healthcare Group (ASKER.SS), Sinch (SINCH.SS), Electrolux Professional (EPRO.B.SS), NCAB Group (NCAB.SS), HANZA AB (HANZA.SS), Stillfront Group (SF.SS), Devyser Diagnostics (DVYSR.SS), Studsvik (SVIK.SS)

        • Switzerland: Givaudan (GIVN.SW), Chocoladefabriken Lindt & Spruengli (LISN.SW), Julius Baer Group (BAER.SW), Temenos (TEMN.SW), ALSO Holding (ALSN.SW), Dätwyler Holding (DAE.SW), Bossard Holding (BOSN.SW)

        • UK: ME Group International (MEGP.LN), Arbuthnot Banking Group (ARBB.LN), TheWorks.co.uk (WRKS.LN)

      • Trading Statement:

        • France: SOITEC (SOI.FP), Ubisoft Entertainment (UBI.FP), Roche Bobois (RBO.FP), Vente-Unique.com (ALVU.FP), HighCo (HCO.FP)

        • UK: Compass Group (CPG.LN), Mitie Group (MTO.LN), Kier Group (KIE.LN), Evoke (EVOK.LN), Luceco (LUCE.LN), Ecora Resources (ECOR.LN), ASA International Group (ASAI.LN), hVIVO (HVO.LN)

  • Data:

    • Economics:

      • UK Jul house price index +0.1% y/y vs prior +0.8%; reducing price forecast for 2025 from +4% to +2% - Rightmove

    • Markets:

      • WTI Crude (Aug 25): ($0.27) or (0.40%) to $67.07

      • €-$ +0.0084 or +0.72% to 1.1714

      • £-$ +0.0087 or +0.65% to 1.3504

      • €-£ +0.0005 to 0.8675

      • S&P 500 +0.60%

      • Performance year-to-date:

        • FTSE 100: +10.28%

        • DAX: +22.09%

        • CAC: +5.66%

        • MIB: +17.49%

        • Stoxx 600: +7.68%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE